Evidence map›Paper›PMID 24077456›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2013

Radioprotection of lung tissue by soy isoflavones.

Gilda G Hillman, Vinita Singh-Gupta, Fulvio Lonardo, David J Hoogstra, Lisa M Abernathy, Christopher K Yunker, Shoshana E Rothstein, Joseph Rakowski, Fazlul H Sarkar, Shirish Gadgeel and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Radiomitigators: Breakthroughs in Post-Radiation Recovery.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2015
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Gilda G HillmanDepartments of *Radiation Oncology, †Immunology and Microbiology, ‡Pathology, and §Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Vinita Singh-Gupta
Fulvio Lonardo
David J Hoogstra
Lisa M Abernathy
Christopher K Yunker
Shoshana E Rothstein
Joseph Rakowski
Fazlul H Sarkar
Shirish Gadgeel
Andre A Konski
Michael C Joiner
The Barbara Ann Karmanos Cancer Institute · USWayne State University · US

Funding

Soy isoflavones to augment radiotherapy of lung carcinomaR21CA155518 · NCI · WAYNE STATE UNIVERSITY · PI HILLMAN, GILDA G · 2011 to 2012
$347k
NCI NIH HHS 1R21CA155518-01A1NCI NIH HHS R21 CA155518
6 · The paper itself

Abstract

introductionRadiation-induced pneumonitis and fibrosis have restricted radiotherapy for lung cancer. In a preclinical lung tumor model, soy isoflavones showed the potential to enhance radiation damage in tumor nodules and simultaneously protect normal lung from radiation injury. We have further dissected the role of soy isoflavones in the radioprotection of lung tissue.

methodsNaive Balb/c mice were treated with oral soy isoflavones for 3 days before and up to 4 months after radiation. Radiation was administered to the left lung at 12 Gy. Mice were monitored for toxicity and breathing rates at 2, 3, and 4 months after radiation. Lung tissues were processed for histology for in situ evaluation of response.

resultsRadiation caused damage to normal hair follicles, leading to hair loss in the irradiated left thoracic area. Supplementation with soy isoflavones protected mice against radiation-induced skin injury and hair loss. Lung irradiation also caused an increase in mouse breathing rate that was more pronounced by 4 months after radiation, probably because of the late effects of radiation-induced injury to normal lung tissue. However, this effect was mitigated by soy isoflavones. Histological examination of irradiated lungs revealed a chronic inflammatory infiltration involving alveoli and bronchioles and a progressive increase in fibrosis. These adverse effects of radiation were alleviated by soy isoflavones.

conclusionSoy isoflavones given pre- and postradiation protected the lungs against adverse effects of radiation including skin injury, hair loss, increased breathing rates, inflammation, pneumonitis and fibrosis, providing evidence for a radioprotective effect of soy.

Indexed as

AlopeciaAnimalsDietary SupplementsDose-Response Relationship, RadiationFemaleGlycine maxIsoflavonesLungMiceMice, Inbred BALB CPhotonsPulmonary FibrosisRadiation PneumonitisRadiation-Protective AgentsRespiratory MechanicsSkinIsoflavonesRadiation-Protective Agents

Identifiers

PMID24077456
PMCPMC3800250
OpenAlexW2076776780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.